B. Polack et al., Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease, BIOC BIOP R, 275(3), 2000, pp. 854-858
Citations number
26
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Bacterial type III secretion system drives the translocation of virulence f
actors into the cystosol of host target cells. In phagocytes and in Epstein
-Barr virus immortalized B lymphocytes, NADPH oxidase generates O-2(-) thro
ugh an electron transfer chain the activity of which depends on the assembl
y of three, p67(phox), p47(phox) and p40(phox) cytosolic activating factors
with Rac 1/2 and a membrane redox component, cytochrome b(558). In p67(pho
x) deficient chronic granulomatous disease (CGD) patients, p67-phox is miss
ing and NADPH oxidase activity is abolished. ExoS is a virulence factor of
Pseudomonas aeruginosa which is secreted via the type III secretion system:
it was fused with p67(phox). Pseudomonas aeruginosa synthesized and transl
ocated the hybrid ExoS-p67(phox) fusion protein into the cytosol of B lymph
ocytes via the type III secretion system. Purified ExoS-p67(phox) hybrid pr
otein was as efficient as normal recombinant p67(phox) cell-free reconstitu
tion of NADPH oxidase activity. Therefore, ExoS-p67(phox) was transferred v
ia the type III secretion system of Pseudomonas aeruginosa into the cytosol
of B lymphocytes from a p67(phox)-deficient CGD patient and functionally r
econstituted NADPH oxidase activity. In the complementation process,ExoS ac
ted as a molecular courier for protein delivery: the reconstitution of an a
ctive NADPH oxidase complex suggests type III secretion system to be a new
approach for cellular therapy. (C) 2000 Academic Press.